IRIS

Sfoglia per Rivista  ALIMENTARY PHARMACOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 38 a 57 di 102
Titolo Data di pubblicazione Autore(i) File
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection 1-gen-2000 Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 1-gen-2010 Szabo, H; Fiorino, G; Danese, S
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy 1-gen-1999 Rinaldi, V; Zullo, A; De Francesco, V; Hassan, Cesare; Winn, S; Stoppino, V; Faleo, D; Attili, Af
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 1-gen-2018 Persico, M; Aglitti, A; Aghemo, A; Rendina, M; Lleo, A; Ciancio, A; Di Marco, V; Lampertico, P; Brunetto, Mr; Zuin, M; Andreone, P; Villa, E; Troshina, G; Calvaruso, V; Degasperi, E; Coco, B; Giorgini, A; Conti, F; Di Leo, A; Marzi, L; Boccaccio, V; Bollani, S; Maisonneuve, P; Bruno, S
High eradication rates of Helicobacter pylori with a new sequential treatment 1-gen-2003 Zullo, A; Vaira, D; Vakil, N; Hassan, Cesare; Gatta, L; Ricci, Carlo Antonio; De Francesco, V; Menegatti, M; Tampieri, A; Perna, Francesco; Rinaldi, V; Perri, Fabio; Papadìa, C; Fornari, F; Pilati, S; Mete, Ls; Merla, Antonio; Potì, R; Marinone, G; Savioli, A; Campo, Sma; Faleo, D; Ierardi, E; Miglioli, M; Morini, S.
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 1-gen-2005 Zullo, A; Gatta, L; De Francesco, V; Hassan, Cesare; Ricci, Carlo Antonio; Bernabucci, V; Cavina, Mariateresa; Ierardi, E; Morini, S; Vaira, D.
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin 1-gen-2012 Valenti, L; Aghemo, A; Stattermayer, Af; Maggioni, P; De Nicola, S; Motta, Bm; Rumi, Mg; Dongiovanni, P; Ferenci, P; Colombo, M; Fargion, S
Increased carotid intima-media thickness in patients with inflammatory bowel disease 1-gen-2005 Papa, A; Santoliquido, A; Danese, S; Covino, M; Di Campli, C; Urgesi, R; Grillo, A; Guglielmo, S; Tondi, P; Guidi, L; De Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies 1-gen-2015 Sandborn, Wj; Danese, S; D'Haens, G; Moro, L; Jones, R; Bagin, R; Huang, M; Ballard, Ed; Masure, J; Travis, S
Inflammatory bowel disease: estimates from the global burden of disease 2017 study 1-gen-2020 Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up 1-gen-2007 Kohn, A; Daperno, M; Armuzzi, A; Cappello, M; Biancone, L; Orlando, A; Viscido, A; Annese, V; Riegler, G; Meucci, G; Marrollo, M; Sostegni, R; Gasbarrini, A; Peralta, S; Prantera, C
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series 1-gen-2011 Rahier, Jf; Papay, P; Salleron, J; Sebastian, S; Ellul, P; Teich, N; Fiorino, G; Blaha, B; GARCIA-SANCHEZ, V; Haas, T; VAN GOSSUM, A; Abitbol, V; Yazdanpanah, Y; Chaparro, Mc
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply 1-gen-2020 Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines 1-gen-2014 Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients 1-gen-2017 Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation 1-gen-2013 Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P
Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre-cohort analysis. Authors' reply 1-gen-2023 Piovani, D.; Tsantes, A. G.; Schunemann, H. J.; Bonovas, S.
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy 1-gen-2021 Privitera, G; Pugliese, D; Scaldaferri, F; Armuzzi, A
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply 1-gen-2020 Sandborn, William J; Panés, Julian; Sands, Bruce E; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V; Modesto, Irene; Quirk, Daniel; Danese, Silvio
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease 1-gen-2016 Fraquelli, M.; Baccarin, A.; Casazza, G.; Conti, C. B.; Giunta, M.; Massironi, S.; Invernizzi, F.; Donato, M. F.; Maggioni, M.; Aghemo, A.; Conte, D.; Colombo, M.
Mostrati risultati da 38 a 57 di 102
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile